Lv2
148 积分 2024-04-26 加入
Defining immune reset: achieving sustained remission in autoimmune diseases
4天前
已完结
Recent advances in cellular immunotherapy for immune‐mediated rheumatic diseases
7天前
已完结
Current Biomarkers of IgA Nephropathy
10天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
12天前
已完结
Idiopathic inflammatory myopathies: current insights and future frontiers
12天前
已完结
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
20天前
已完结
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
20天前
已完结
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective
27天前
已完结
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager
27天前
已完结
A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discovery
28天前
已完结
皖公网安备34019202002308
